References
- Lu J-M, Guo X-H, Lv XF, et al. Effects of nateglinide on postprandial plasma glucose excursion and metabolism of lipids in Chinese Patients with type 2 diabetes: a 4-week, randomized, active-control, open-label, parallel-group, multicenter trial. Curr Med Res Opin 2013: in press doi: 10.1185/03007995.2012.713340
- Gaggini M, Morelli M, Buzzigoli E, et al. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013;5:1544-60
- Standl E. Dysglycemia and abdominal obesity. Curr Vasc Pharmacol 2012;10:678-9
- Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008;10:156-64
- Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. Curr Vasc Pharmacol 2013 Apr 25 [Epub ahead of print]
- Mathew M, Tay E, Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol 2010;9:9
- Kolovou G, Ooi TC. Postprandial lipaemia and vascular disease. Curr Opin Cardiol 2013;28:446-51
- Kolovou GD, Mikhailidis DP, Kovar J, et al. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol 2011;9:258-70
- Kolovou GD, Anagnostopoulou KK, Salpea KD, et al. The effect of statins on postprandial lipemia. Curr Drug Targets 2007;8:551-60
- Kolovou GD, Anagnostopoulou KK, Kostakou PM, et al. Cholesterol ester transfer protein (CETP), postprandial lipemia and hypolipidemic drugs. Curr Med Chem 2009;16:4345-60